Pfizer and BioNTech Submit COVID-19 Vaccine Stability Data at Standard Freeze Temperature to the U.S. FDA

Pfizer and BioNTech announced the submission of new data to the U.S. Food and Drug Administration (FDA) demonstrating the stability of their COVID-19 vaccine when stored at -25°C to -15°C (-13°F to 5°F), temperatures more commonly found in pharmaceutical freezers and refrigerators.

Read the full article.